Powered by RND
PodcastsEducationResusX:Podcast

ResusX:Podcast

Haney Mallemat
ResusX:Podcast
Latest episode

Available Episodes

5 of 140
  • Comparative efficacy of remifentanil and fentanyl in mechanically ventilated ICU patients: a systematic review and meta‐analysis on ventilation duration and delirium incidence
    In today’s episode, we’re diving into a game-changing question: Can swapping fentanyl for remifentanil help ventilated ICU patients breathe on their own sooner, and with fewer complications like delirium? This fresh meta-analysis pulls data from multiple studies and suggests remifentanil could reduce ventilation time by up to 21 hours in some cases and may lower the risk of ICU-related delirium. While the evidence is still growing and more rigorous trials are needed, the findings raise big questions about how we manage pain and recovery in critical care. Tune in for key takeaways, clinical implications, and what this could mean for the future of ICU sedation. Want to go deeper? Read the full study: "Comparative efficacy of remifentanil and fentanyl in mechanically ventilated ICU patients: a systematic review and meta-analysis on ventilation duration and delirium incidence" by Hiromu Okano et al. in Journal of Anesthesia, Analgesia and Critical Care.
    --------  
    11:32
  • Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients
    When it comes to oxygen therapy for critically ill, ventilated patients, more isn’t always better—but is less the answer? The UK-ROX trial set out to find out, tracking over 16,000 ICU patients across 97 hospitals to test if targeting lower oxygen saturation (SpO₂ ~90%) could improve survival rates. Spoiler alert: it didn’t. In this episode, we unpack why conservative oxygen therapy didn’t significantly impact 90-day mortality—and what that means for frontline ICU care today. With no meaningful differences in mortality, ICU stays, or days free from organ support, the results suggest that “usual care” oxygen strategies may already be doing the job. Key takeaways: • Conservative O₂ therapy didn’t improve survival • 90-day mortality nearly identical across groups • Usual care remains a safe and effective standard Breathe easy—this episode cuts through the noise and gives you the real clinical takeaways. Want to dig deeper? Check out the full study: "Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients" by Daniel S. Martin et al., published in JAMA.
    --------  
    14:36
  • The association between integrating echocardiography use in the management of septic shock patients and outcomes in the intensive care unit: a systematic review and meta‐analysis
    Can Ultrasound Save Lives in Septic Shock? Septic shock is a race against time, and now, there's a powerful new tool at the bedside. A recent meta-analysis of nearly 4,000 ICU patients reveals that using point-of-care echocardiography (POC echo) to guide treatment slashes mortality rates by up to 18%. In this episode, we dive into how this quick bedside ultrasound isn't just helping docs see more—it’s changing decisions, improving outcomes, and getting organs back on track faster. From better inotropic support to quicker lactate clearance, POC echo might just be the new game-changer in critical care. Tune in and learn how this visual tool could be the lifeline in septic shock. Want the full breakdown? Check out “The association between integrating echocardiography use in the management of septic shock patients and outcomes in the intensive care unit” by Keith Killu et al., in the Journal of Ultrasound (2025). #CriticalCare #SepticShock #POCecho #UltrasoundInICU #ResusTalks #ICUpodcast #EmergencyMedicine #SepsisAwareness
    --------  
    14:34
  • Norepinephrine versus epinephrine after cardiac arrest: A systematic review and meta-analysis
    Restarting the heart is only half the fight—what comes next could make or break recovery. In this episode, we dive into the high-stakes world of post-resuscitation shock and a game-changing debate: epinephrine or norepinephrine? New data from over 3,400 patients suggests norepi might dramatically cut the risk of a second cardiac arrest—by 63%! That’s huge. But does it impact survival? Brain function? Tune in as we unpack the numbers, the controversy, and what it all means for your resus playbook. Want more details? Check out the full study "Norepinephrine versus epinephrine after cardiac arrest: A systematic review and meta-analysis" by Caitlin A. Williams et al. in the American Journal of Emergency Medicine.
    --------  
    16:45
  • Excuse My Resuscitation
    In this podcast episode, resus pros Swami, Mike, and Steve go head-to-head on the hottest controversies in emergency and critical care medicine. From the great bougie vs. stylet debate to the ethics of prehospital whole blood and the eternal neuro RSI paralytic showdown — nothing is off-limits. We talk: Bougie every time? Or nah? Should every ambulance carry blood? Succinylcholine vs. rocuronium for neuro patients How to train airway newbies — VL or DL first? Whether you’re an airway nerd, trauma junkie, or just love good old-fashioned resus banter, this episode delivers clinical pearls with a side of attitude. Grab your stopwatch — the clock is ticking! Tune in now, and don’t forget to bring your strong opinions.
    --------  
    16:48

More Education podcasts

About ResusX:Podcast

Welcome to the ResusX:Podcast. Each episode features an amazing talk from the ResusX conference. This is a podcast dedicated to your sickest patients, and it'll all FOAMed. For more great content including our monthly grand rounds, newsletters and more go to www.ResusX.com now.
Podcast website

Listen to ResusX:Podcast, The Gratitude Attitude Podcast and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features
Social
v7.19.0 | © 2007-2025 radio.de GmbH
Generated: 7/1/2025 - 6:19:01 AM